So sánh phương pháp
Xem các phương pháp đã chọn cạnh nhau; những hàng khác biệt được làm nổi bật.
| Phân tích Rủi ro Cạnh tranh Điều chỉnh Rủi ro× | Ghép cặp điểm xu hướng× | |
|---|---|---|
| Lĩnh vực≠ | Dịch tễ học | Thống kê nghiên cứu |
| Họ | Process / pipeline | Process / pipeline |
| Năm ra đời≠ | 1999 (subdistribution hazard model); cause-specific hazard framework earlier | 1983 |
| Người khởi xướng≠ | Jason Fine and Robert Gray | Paul Rosenbaum and Donald Rubin |
| Loại≠ | Regression model for time-to-event data with competing events | Method |
| Công trình gốc≠ | Fine, J. P., & Gray, R. J. (1999). A proportional hazards model for the subdistribution of a competing risk. Journal of the American Statistical Association, 94(446), 496–509. DOI ↗ | Rosenbaum, P. R., & Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70(1), 41–55. DOI ↗ |
| Tên gọi khác≠ | competing risks regression, subdistribution hazard model, cause-specific hazard analysis, Fine-Gray model | PSM, propensity score weighting, covariate balance |
| Liên quan≠ | 4 | 3 |
| Tóm tắt≠ | Risk-adjusted competing risks analysis extends classical survival analysis to settings where subjects can experience more than one type of terminal event, and where the occurrence of one event prevents the occurrence of another. By modelling cause-specific or subdistribution hazards while adjusting for measured confounders, the method yields unbiased estimates of the absolute probability — the cumulative incidence function — of each event type over time in the presence of competing events. | Propensity score matching (PSM) is a method for reducing confounding bias in observational studies by balancing baseline characteristics between treatment groups, simulating randomization. Developed by Rosenbaum and Rubin (1983), it estimates the probability of receiving treatment given observed covariates, then matches or weights treated and control individuals with similar treatment probabilities. Widely used in medicine, epidemiology, and policy evaluation when randomized trials are infeasible or unethical, enabling estimation of treatment effects while controlling for selection bias. |
| ScholarGateBộ dữ liệu ↗ |
|
|